3h
Vietnam Investment Review on MSNLion TCR s Liocyx M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV Related Hepatocellular CarcinomaOn 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...
A renewed and expanded effort from chemical giant Bayer to shield itself from lawsuits that claim its popular weedkiller Roundup causes cancer brought dozens of protesters to the Iowa Capitol building ...
The federal order temporarily halts the Trump administration’s plans to slash $4 billion in overhead costs for research at ...
Eating well can help support your immune system and maintain strength and energy if you have HER2-negative breast cancer, ...
Turmeric and honey contain beneficial compounds that can help reduce inflammation, improve metabolic health, and aid in ...
A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...
Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...
The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...
If approved, SB 560 would prohibit restaurants from manufacturing, selling, or distributing food containing certain chemical additives, including red dye 3, blue dye, 1, yellow dye 5 and potassium ...
The U.K. biopharmaceutical company said data from a Phase 2 study of eRapa, a treatment for familial adenomatous polyposis, showed the drug to be safe and well-tolerated among users. The treatment ...
Following in California's anti-chemical footsteps, a new Florida bill filed Monday would ban restaurants from selling food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results